Role of non-coding RNAs in response of breast cancer to radiation therapy

Mol Biol Rep. 2022 Jun;49(6):5199-5208. doi: 10.1007/s11033-022-07234-2. Epub 2022 Feb 25.

Abstract

Breast cancer ranks as the first common cancer with a high incidence rate and mortality among women. Radiation therapy is the main therapeutic method for breast cancer patients. However, radiation resistance of tumor cells can reduce the efficacy of treatment and lead to recurrence and mortality in patients. Non-coding RNA (ncRNAs) refers to a group of small RNA molecules that are not translated into protein, while they have the ability to modulate the translation of target mRNA. Several studies have reported the altered expression of ncRNAs in response to radiation in breast cancer. NcRNAs have been found to influence on radiation response of breast cancer by regulating various mechanisms, including DNA damage response, cell cycle regulation, cell death, inflammatory response, cancer stem cell and EGFR related pathways. This paper aimed to provide a summary of current findings on ncRNAs dysregulation after irradiation. We also present the function and mechanism of ncRNAs in modulating radiosensitivity or radioresistance of breast cancer cells.

Keywords: Breast cancer; Non-coding RNA; Radiation resistance; Signal transduction.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / metabolism
  • Breast Neoplasms* / radiotherapy
  • Female
  • Humans
  • Neoplastic Stem Cells / metabolism
  • RNA / metabolism
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism
  • RNA, Untranslated / genetics
  • Radiation Tolerance / genetics

Substances

  • RNA, Long Noncoding
  • RNA, Untranslated
  • RNA